IBM’s Watson and DNA mapping to improve drug prescription process

| February 14, 2014
poster p how ibms entrepreneur of the year uses dna watson to cure drug prescribing
Image via Fast Company. Credit: Procsilas Moscas / Flickr
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Not all patients are the same.

That idea is at the fast-beating heart of a company that was named IBM’s Global Entrepreneur of the Year at last week’s IBM SmartCamp finals. The New Jersey-based for-profit research group Coriell Life Sciences beat out some 1,200 other startups to claim the honor.

President and CEO Scott Megill spoke with Fast Company about how his company’s DNA mapping and tracking works, and how IBM’s Watson is making the process smarter–by analyzing 1,500 scientific papers a month.

The payoff for the company could be massive. According to a report issued last month by In-Demand Research, the value of the world genomics market was about $11.11 billion in 2013.

Read the full, original story: HOW IBM’S ENTREPRENEUR OF THE YEAR USES DNA, WATSON TO CURE DRUG-PRESCRIBING PROBLEMS

Additional Resources:

The GLP featured this article to reflect the diversity of news, opinion and analysis. The viewpoint is the author’s own. The GLP’s goal is to stimulate constructive discourse on challenging science issues.

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend